Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer, LLP reminds investors that a complaint has been filed on behalf of investors who purchased or otherwise acquired the...
-
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer, LLP reminds investors that a complaint has been filed on behalf of investors who purchased or otherwise acquired the common...
-
NEW YORK, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Credit Suisse Group AG’s American Depositary Shares...
-
NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing to investigate claims on behalf of investors in Spectrum Pharmaceuticals, Inc....
-
NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing its investigation of claims on behalf of investors in Y-mAbs Therapeutics, Inc....
-
NEW YORK, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of G-III Apparel Group Ltd. (“G-III” or “Company”)...
-
NEW YORK, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Olaplex Holdings, Inc. (NASDAQ: OLPX), a company...